Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Marlio Charles Mosseri files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ron Bentsur - $279K in NVCT purchases and sales in the last 12 months
- Juan Sanchez - $75K in NVCT purchases and sales in the last 12 months
- Matthew L. Kaplan - $64K in NVCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marlio Charles Mosseri?
Marlio Charles Mosseri is a corporate insider, tracked as 10% Owner of Nuvectis Pharma, Inc. (NVCT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Marlio Charles Mosseri last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 3 filings going back to 2024.
Has Marlio Charles Mosseri been buying or selling stock?
Recorded transactions: 5 open-market purchases ($1.95M) and 0 open-market sales across all tracked filings.
